When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ABOS - Acumen Pharmaceuticals GAAP EPS of -$0.23 misses by $0.06
Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals press release (NASDAQ:ABOS): Q1 GAAP EPS of -$0.23 misses by $0.06. Topline results expected in the first half of 2023 from INTERCEPT-AD, a multi-center, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose Phase 1 clinical trial of ACU193 in patients with early Alzheimer’s disease. $216.7M in cash, cash equivalents and marketable securities is expected to provide cash runway through 2025.